IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v45y2022i5d10.1007_s40264-022-01170-7.html
   My bibliography  Save this article

Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources

Author

Listed:
  • Likeng Liang

    (South China Normal University)

  • Jifa Hu

    (Huazhong University of Science and Technology)

  • Gang Sun

    (The Affiliated Cancer Hospital of Xinjiang Medical University)

  • Na Hong

    (Digital Health China Technologies Co., Ltd.)

  • Ge Wu

    (Digital Health China Technologies Co., Ltd.)

  • Yuejun He

    (Digital Health China Technologies Co., Ltd.)

  • Yong Li

    (South China Normal University)

  • Tianyong Hao

    (South China Normal University)

  • Li Liu

    (Southern Medical University)

  • Mengchun Gong

    (Southern Medical University)

Abstract

With the rapid development of artificial intelligence (AI) technologies, and the large amount of pharmacovigilance-related data stored in an electronic manner, data-driven automatic methods need to be urgently applied to all aspects of pharmacovigilance to assist healthcare professionals. However, the quantity and quality of data directly affect the performance of AI, and there are particular challenges to implementing AI in limited-resource settings. Analyzing challenges and solutions for AI-based pharmacovigilance in resource-limited settings can improve pharmacovigilance frameworks and capabilities in these settings. In this review, we summarize the challenges into four categories: establishing a database for an AI-based pharmacovigilance system, lack of human resources, weak AI technology and insufficient government support. This study also discusses possible solutions and future perspectives on AI-based pharmacovigilance in resource-limited settings.

Suggested Citation

  • Likeng Liang & Jifa Hu & Gang Sun & Na Hong & Ge Wu & Yuejun He & Yong Li & Tianyong Hao & Li Liu & Mengchun Gong, 2022. "Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources," Drug Safety, Springer, vol. 45(5), pages 511-519, May.
    • Handle: RePEc:spr:drugsa:v:45:y:2022:i:5:d:10.1007_s40264-022-01170-7
    DOI: 10.1007/s40264-022-01170-7
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-022-01170-7
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-022-01170-7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Abbie Barry & Sten Olsson & Omary Minzi & Emile Bienvenu & Eyasu Makonnen & Appolinary Kamuhabwa & Margaret Oluka & Anastasia Guantai & Ulf Bergman & Eugène Puijenbroek & Parthasarathi Gurumurthy & El, 2020. "Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania," Drug Safety, Springer, vol. 43(4), pages 339-350, April.
    2. Justin Mower & Trevor Cohen & Devika Subramanian, 2020. "Complementing Observational Signals with Literature-Derived Distributed Representations for Post-Marketing Drug Surveillance," Drug Safety, Springer, vol. 43(1), pages 67-77, January.
    3. Corinne Willame & Caitlin Dodd & Lieke van der Aa & Gino Picelli & Hanne-Dorthe Emborg & Johnny Kahlert & Rosa Gini & Consuelo Huerta & Elisa Martín-Merino & Chris McGee & Simon Lusignan & Giuseppe Ro, 2021. "Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project," Drug Safety, Springer, vol. 44(3), pages 383-395, March.
    4. Alec B. Chapman & Kelly S. Peterson & Patrick R. Alba & Scott L. DuVall & Olga V. Patterson, 2019. "Detecting Adverse Drug Events with Rapidly Trained Classification Models," Drug Safety, Springer, vol. 42(1), pages 147-156, January.
    5. Qun-Ying Yue, 2021. "The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance," Drug Safety, Springer, vol. 44(6), pages 615-617, June.
    6. Susmitha Wunnava & Xiao Qin & Tabassum Kakar & Cansu Sen & Elke A. Rundensteiner & Xiangnan Kong, 2019. "Adverse Drug Event Detection from Electronic Health Records Using Hierarchical Recurrent Neural Networks with Dual-Level Embedding," Drug Safety, Springer, vol. 42(1), pages 113-122, January.
    7. Abhyuday Jagannatha & Feifan Liu & Weisong Liu & Hong Yu, 2019. "Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0)," Drug Safety, Springer, vol. 42(1), pages 99-111, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Feifan Liu & Abhyuday Jagannatha & Hong Yu, 2019. "Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records," Drug Safety, Springer, vol. 42(1), pages 95-97, January.
    2. Hui Xing Tan & Chun Hwee Desmond Teo & Pei San Ang & Wei Ping Celine Loke & Mun Yee Tham & Siew Har Tan & Bee Leng Sally Soh & Pei Qin Belinda Foo & Zheng Jye Ling & Wei Luen James Yip & Yixuan Tang &, 2022. "Combining Machine Learning with a Rule-Based Algorithm to Detect and Identify Related Entities of Documented Adverse Drug Reactions on Hospital Discharge Summaries," Drug Safety, Springer, vol. 45(8), pages 853-862, August.
    3. Siun Kim & Taegwan Kang & Tae Kyu Chung & Yoona Choi & YeSol Hong & Kyomin Jung & Howard Lee, 2023. "Automatic Extraction of Comprehensive Drug Safety Information from Adverse Drug Event Narratives in the Korea Adverse Event Reporting System Using Natural Language Processing Techniques," Drug Safety, Springer, vol. 46(8), pages 781-795, August.
    4. Abhyuday Jagannatha & Feifan Liu & Weisong Liu & Hong Yu, 2019. "Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0)," Drug Safety, Springer, vol. 42(1), pages 99-111, January.
    5. Heba Edrees & Wenyu Song & Ania Syrowatka & Aurélien Simona & Mary G. Amato & David W. Bates, 2022. "Intelligent Telehealth in Pharmacovigilance: A Future Perspective," Drug Safety, Springer, vol. 45(5), pages 449-458, May.
    6. Abbie Barry & Sten Olsson & Christabel Khaemba & Joseph Kabatende & Tigist Dires & Adam Fimbo & Omary Minzi & Emile Bienvenu & Eyasu Makonnen & Appolinary Kamuhabwa & Margaret Oluka & Anastasia Guanta, 2021. "Comparative Assessment of the Pharmacovigilance Systems within the Neglected Tropical Diseases Programs in East Africa—Ethiopia, Kenya, Rwanda, and Tanzania," IJERPH, MDPI, vol. 18(4), pages 1-13, February.
    7. Andrea Spini & Giulia Hyeraci & Claudia Bartolini & Sandra Donnini & Pietro Rosellini & Rosa Gini & Marina Ziche & Francesco Salvo & Giuseppe Roberto, 2021. "Real-World Utilization of Target- and Immunotherapies for Lung Cancer: A Scoping Review of Studies Based on Routinely Collected Electronic Healthcare Data," IJERPH, MDPI, vol. 18(14), pages 1-21, July.
    8. Shungo Imai & Yoh Takekuma & Hitoshi Kashiwagi & Takayuki Miyai & Masaki Kobayashi & Ken Iseki & Mitsuru Sugawara, 2020. "Validation of the usefulness of artificial neural networks for risk prediction of adverse drug reactions used for individual patients in clinical practice," PLOS ONE, Public Library of Science, vol. 15(7), pages 1-12, July.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:45:y:2022:i:5:d:10.1007_s40264-022-01170-7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.